GEUS-CLL is a MULTI-Analyte In Vitro Diagnostics Test for Chronic Lymphocytic Leukemia (CLL)

  • Certified next generation sequencing-based in vitro diagnostic test for diagnosis, prognosis and treatment selection in CLL patients.
  • Designed in collaboration with leading leukemia researchers and hemato-oncologists.
  • All-in-one solution integrating clinically-relevant genetic and epigenetic alterations in CLL.
  • Bolt-on workflow from library preparation to clinical report.
  • Higher data quality than current solutions.
  • Cost-effective, time-efficient solution replacing multiple tests and reducing turnaround times.